FDA Clears Leucovorin for an Ultra-Rare Disorder — Not for Autism What You Need to Know at a Glance The FDA has approved leucovorin for a very rare genetic condition, not for autism. The newly approved use is for cerebral folate deficiency linked to a FOLR1 gene variant, an ultra-rare disorder affecting fewer than 1
FDA Limits Leucovorin Approval to Rare Folate Deficiency Disorder Read More »
Typhoid Superbug Alert: The Ancient Infection Fighting Back Quick Summary — What You Need to Know Typhoid fever is rapidly becoming antibiotic-resistant worldwide. Extensively drug-resistant (XDR) strains now resist most first-line treatments. Azithromycin, the last reliable oral antibiotic, is under threat. Over 13 million cases were reported globally in 2024. Drug-resistant strains have spread from
Typhoid Superbug Warning: Rising Antibiotic Resistance Read More »
Novo Nordisk plans major U.S. list price cuts for Ozempic and Wegovy starting January 2027 Intro Novo Nordisk says it will lower the U.S. list prices of its blockbuster GLP-1 medicines — Wegovy, Ozempic, and Rybelsus — starting January 1, 2027. The company says the goal is to reduce out-of-pocket costs for people whose payments
Novo Nordisk to Cut Ozempic & Wegovy List Prices Up to 50% in 2027 Read More »
Novo Nordisk stumbles again: CagriSema trails Lilly’s Zepbound in key trial Novo said its next-gen obesity drug CagriSema hit 23% weight loss at 84 weeks, but it failed to prove non-inferiority versus Lilly’s tirzepatide (Zepbound) at 25.5%. Novo stock dropped about 15–16% on the day across reports; several outlets also cited a steep 12-month decline.
Novo Nordisk CagriSema Misses Non-Inferiority vs Lilly Zepbound Read More »
Seychelles Travel Alert: Chikungunya Outbreak — What Travelers Must Know Quick Summary Seychelles is experiencing an active chikungunya outbreak The virus spreads through mosquito bites (Aedes mosquitoes) CDC issued a Level 2 advisory: practice enhanced precautions Symptoms include fever, severe joint pain, rash, fatigue, and headaches Vaccination is recommended for travelers visiting outbreak zones Pregnant
CDC Issues Travel Advisory for Seychelles Virus Outbreak Read More »
FDA Blocks Moderna’s mRNA Flu Vaccine Review — What It Means for the Future of Vaccine Innovation Quick Summary (Key Points) The FDA refused to review Moderna’s new mRNA flu vaccine application The rejection wasn’t about safety or effectiveness The agency said the clinical trial comparison wasn’t strong enough Moderna says the FDA previously approved
FDA Blocks Moderna mRNA Flu Vaccine Review — Policy Shock Explained Read More »
Nipah Virus Explained: What You Must Know as Asia Tightens Health Alerts Quick Summary (Key Facts at a Glance) Nipah virus is a highly deadly zoonotic disease that spreads from animals to humans Fatality rate ranges between 40%–75%, with no approved vaccine or treatment Two confirmed cases have been reported in West Bengal, India, since
Nipah Virus Explained: Symptoms, Spread & India Alert Read More »
Trump Unveils Healthcare Plan Aimed at Reducing Costs for Americans Summary: Trump’s Healthcare Plan to Lower Costs and Increase Transparency President Donald Trump unveiled a comprehensive healthcare proposal aimed at lowering prescription drug prices and insurance premiums. The plan focuses on sending healthcare subsidy money directly to consumers instead of insurance companies. It proposes
Trump Unveils New Healthcare Plan to Cut Costs and Lower Premiums Read More »
Flu Cases Are Surging Across the United States in 2026 Flu Surge in the U.S. — Key Summary Points Flu activity has reached record-high levels across the United States this season. 8% of all medical visits were flu-related in the week ending December 27 — the highest since 1997. 120,000 hospitalizations and 5,000 deaths have
Flu Cases Surge Across the U.S. as New H3N2 Strain Spreads Read More »
FDA Approves Wegovy Pill: A Breakthrough in Oral GLP-1 Weight Loss Medication Summary : FDA Approval: The FDA has approved Wegovy’s first-ever oral version, a weight-loss pill from Novo Nordisk containing semaglutide, the active ingredient in both Wegovy and Ozempic. Pill vs. Injection: This new pill version offers a daily oral alternative to
FDA Approves Wegovy Oral Pill for Weight Loss | New GLP-1 Treatment Read More »